

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 9.78924243 |
| 2 | eosinophil migration (GO:0072677) | 9.38517462 |
| 3 | regulation of sister chromatid cohesion (GO:0007063) | 8.87817084 |
| 4 | regulation of mononuclear cell migration (GO:0071675) | 8.72497310 |
| 5 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 8.46070278 |
| 6 | L-fucose catabolic process (GO:0042355) | 8.12234253 |
| 7 | fucose catabolic process (GO:0019317) | 8.12234253 |
| 8 | L-fucose metabolic process (GO:0042354) | 8.12234253 |
| 9 | ribosomal small subunit assembly (GO:0000028) | 7.88159968 |
| 10 | branch elongation of an epithelium (GO:0060602) | 7.73841856 |
| 11 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 7.56657274 |
| 12 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 7.21396828 |
| 13 | positive regulation of chromosome segregation (GO:0051984) | 7.15660806 |
| 14 | vesicle fusion (GO:0006906) | 7.09242381 |
| 15 | coenzyme A biosynthetic process (GO:0015937) | 6.92744140 |
| 16 | autophagic vacuole fusion (GO:0000046) | 6.70362130 |
| 17 | peptidyl-lysine dimethylation (GO:0018027) | 6.62030652 |
| 18 | macrophage chemotaxis (GO:0048246) | 6.29630002 |
| 19 | organ growth (GO:0035265) | 6.17182860 |
| 20 | protein import into peroxisome matrix (GO:0016558) | 6.04587757 |
| 21 | localization within membrane (GO:0051668) | 5.85481781 |
| 22 | positive regulation of calcium ion import (GO:0090280) | 5.67396363 |
| 23 | axis elongation (GO:0003401) | 5.56122443 |
| 24 | establishment of mitotic spindle orientation (GO:0000132) | 5.54379056 |
| 25 | regulation of T cell receptor signaling pathway (GO:0050856) | 5.46298111 |
| 26 | monocyte chemotaxis (GO:0002548) | 5.37149804 |
| 27 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 5.34274516 |
| 28 | negative regulation of GTPase activity (GO:0034260) | 5.26204973 |
| 29 | negative regulation of GTP catabolic process (GO:0033125) | 5.26204973 |
| 30 | regulation of beta-amyloid formation (GO:1902003) | 5.25151774 |
| 31 | organelle membrane fusion (GO:0090174) | 5.22568032 |
| 32 | non-recombinational repair (GO:0000726) | 5.03640621 |
| 33 | double-strand break repair via nonhomologous end joining (GO:0006303) | 5.03640621 |
| 34 | acrosome assembly (GO:0001675) | 4.94511355 |
| 35 | establishment of mitotic spindle localization (GO:0040001) | 4.85818940 |
| 36 | establishment of spindle orientation (GO:0051294) | 4.74603027 |
| 37 | oxidative demethylation (GO:0070989) | 4.66938231 |
| 38 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 4.47054768 |
| 39 | organelle fusion (GO:0048284) | 4.42700324 |
| 40 | fucosylation (GO:0036065) | 4.37298634 |
| 41 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 4.33414078 |
| 42 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 4.33414078 |
| 43 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 4.33414078 |
| 44 | fucose metabolic process (GO:0006004) | 4.33053841 |
| 45 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 4.28698263 |
| 46 | positive chemotaxis (GO:0050918) | 4.26898008 |
| 47 | regulation of stem cell maintenance (GO:2000036) | 4.26375565 |
| 48 | histone H3-K9 methylation (GO:0051567) | 4.26361783 |
| 49 | pantothenate metabolic process (GO:0015939) | 4.23714911 |
| 50 | seminiferous tubule development (GO:0072520) | 4.23166242 |
| 51 | negative regulation of circadian rhythm (GO:0042754) | 4.15772248 |
| 52 | regulation of autophagic vacuole assembly (GO:2000785) | 4.14219546 |
| 53 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 4.10454930 |
| 54 | coenzyme A metabolic process (GO:0015936) | 4.08524682 |
| 55 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 4.07113642 |
| 56 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 3.92240560 |
| 57 | protein localization to peroxisome (GO:0072662) | 3.90186092 |
| 58 | protein targeting to peroxisome (GO:0006625) | 3.90186092 |
| 59 | establishment of protein localization to peroxisome (GO:0072663) | 3.90186092 |
| 60 | sodium-independent organic anion transport (GO:0043252) | 3.85738600 |
| 61 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.84425886 |
| 62 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.81841147 |
| 63 | protein targeting to vacuole (GO:0006623) | 3.78421495 |
| 64 | protein targeting to lysosome (GO:0006622) | 3.78421495 |
| 65 | establishment of protein localization to vacuole (GO:0072666) | 3.78421495 |
| 66 | negative regulation of macroautophagy (GO:0016242) | 3.77849700 |
| 67 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.77395832 |
| 68 | metallo-sulfur cluster assembly (GO:0031163) | 3.74090917 |
| 69 | iron-sulfur cluster assembly (GO:0016226) | 3.74090917 |
| 70 | DNA integration (GO:0015074) | 3.72336458 |
| 71 | peroxisomal transport (GO:0043574) | 3.65980209 |
| 72 | proteasome assembly (GO:0043248) | 3.63697016 |
| 73 | single-organism membrane fusion (GO:0044801) | 3.63583729 |
| 74 | mitochondrial RNA metabolic process (GO:0000959) | 3.62327792 |
| 75 | regulation of fibroblast growth factor receptor signaling pathway (GO:0040036) | 3.59284104 |
| 76 | negative regulation of purine nucleotide catabolic process (GO:0033122) | 3.52222655 |
| 77 | DNA demethylation (GO:0080111) | 3.49671875 |
| 78 | establishment of spindle localization (GO:0051293) | 3.49010360 |
| 79 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.45459616 |
| 80 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.42271477 |
| 81 | negative regulation of nucleotide catabolic process (GO:0030812) | 3.40590029 |
| 82 | telomere maintenance via recombination (GO:0000722) | 3.38711766 |
| 83 | RNA methylation (GO:0001510) | 3.38335800 |
| 84 | negative regulation of nucleoside metabolic process (GO:0045978) | 3.37537398 |
| 85 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.36745590 |
| 86 | histone H3-K9 modification (GO:0061647) | 3.36032413 |
| 87 | regulation of vacuole organization (GO:0044088) | 3.35231611 |
| 88 | regulation of calcium ion import (GO:0090279) | 3.33527564 |
| 89 | membrane budding (GO:0006900) | 3.31114095 |
| 90 | vesicle targeting (GO:0006903) | 3.30063191 |
| 91 | regulation of cellular amide metabolic process (GO:0034248) | 3.25411390 |
| 92 | regulation of peptidyl-threonine phosphorylation (GO:0010799) | 3.15830850 |
| 93 | imidazole-containing compound metabolic process (GO:0052803) | 3.14300862 |
| 94 | prenylation (GO:0097354) | 12.9947411 |
| 95 | protein prenylation (GO:0018342) | 12.9947411 |
| 96 | negative regulation of Ras GTPase activity (GO:0034261) | 11.7295695 |
| 97 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 11.1809613 |
| 98 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 11.1809613 |
| 99 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 11.1809613 |
| 100 | eosinophil chemotaxis (GO:0048245) | 10.3865944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 9.77790249 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 6.13766256 |
| 3 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 4.66884390 |
| 4 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.75973469 |
| 5 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.94569534 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.87427201 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.70086917 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.61739931 |
| 9 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.41935553 |
| 10 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.37820807 |
| 11 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.35385916 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.19190421 |
| 13 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 2.11659630 |
| 14 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 2.05196795 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 10.4756866 |
| 16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.99341625 |
| 17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.91434320 |
| 18 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.82155722 |
| 19 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.69296124 |
| 20 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.67748068 |
| 21 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.59480935 |
| 22 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.59190651 |
| 23 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.59190651 |
| 24 | RXR_22108803_ChIP-Seq_LS180_Human | 1.58889148 |
| 25 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.58820710 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.52315424 |
| 27 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.49117551 |
| 28 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.45414890 |
| 29 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.41426500 |
| 30 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.36517532 |
| 31 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.36501807 |
| 32 | GATA3_26560356_Chip-Seq_TH1_Human | 1.35912262 |
| 33 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.28698043 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.28344789 |
| 35 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.24266973 |
| 36 | TP53_16413492_ChIP-PET_HCT116_Human | 1.22719758 |
| 37 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.11498646 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.10444092 |
| 39 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.09988274 |
| 40 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.08284065 |
| 41 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07898633 |
| 42 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.04506413 |
| 43 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.03879700 |
| 44 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.99656879 |
| 45 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.92367423 |
| 46 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.89657370 |
| 47 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.89363554 |
| 48 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.88682131 |
| 49 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.88682131 |
| 50 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.88236369 |
| 51 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.84609732 |
| 52 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.84291086 |
| 53 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.83467766 |
| 54 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.83194751 |
| 55 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.82080052 |
| 56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.80336498 |
| 57 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79326796 |
| 58 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.78730759 |
| 59 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.78605558 |
| 60 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.78184401 |
| 61 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.76457981 |
| 62 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.76310507 |
| 63 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.76008436 |
| 64 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.74834456 |
| 65 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.74834456 |
| 66 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.74834456 |
| 67 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.74475263 |
| 68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.73476286 |
| 69 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.73451807 |
| 70 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.72763415 |
| 71 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.70662623 |
| 72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.70366698 |
| 73 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.68631534 |
| 74 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.68626699 |
| 75 | P300_19829295_ChIP-Seq_ESCs_Human | 0.68623276 |
| 76 | FUS_26573619_Chip-Seq_HEK293_Human | 0.66790321 |
| 77 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.66094956 |
| 78 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.65925053 |
| 79 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.65436642 |
| 80 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.64743781 |
| 81 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.64743781 |
| 82 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62735871 |
| 83 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.62620241 |
| 84 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62032135 |
| 85 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.61874391 |
| 86 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.61566635 |
| 87 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.61285855 |
| 88 | NCOR_22424771_ChIP-Seq_293T_Human | 0.61016695 |
| 89 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.60302349 |
| 90 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.60238931 |
| 91 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.59865057 |
| 92 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.59865057 |
| 93 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.59747722 |
| 94 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.58892125 |
| 95 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.58876524 |
| 96 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.58438825 |
| 97 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.57544721 |
| 98 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.57273843 |
| 99 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.57179424 |
| 100 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.55850756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 8.85429600 |
| 2 | MP0006082_CNS_inflammation | 5.09629630 |
| 3 | MP0001664_abnormal_digestion | 3.04257936 |
| 4 | MP0001663_abnormal_digestive_system | 3.03380412 |
| 5 | MP0000467_abnormal_esophagus_morphology | 3.01215362 |
| 6 | MP0001919_abnormal_reproductive_system | 2.76024907 |
| 7 | MP0002751_abnormal_autonomic_nervous | 2.75062935 |
| 8 | MP0000383_abnormal_hair_follicle | 2.36668650 |
| 9 | MP0005381_digestive/alimentary_phenotyp | 2.33866922 |
| 10 | MP0003115_abnormal_respiratory_system | 2.25894687 |
| 11 | MP0002876_abnormal_thyroid_physiology | 2.13749829 |
| 12 | MP0000566_synostosis | 12.7441626 |
| 13 | MP0000534_abnormal_ureter_morphology | 1.93385555 |
| 14 | MP0005389_reproductive_system_phenotype | 1.87141954 |
| 15 | MP0003937_abnormal_limbs/digits/tail_de | 1.57972650 |
| 16 | MP0003283_abnormal_digestive_organ | 1.57177264 |
| 17 | MP0005166_decreased_susceptibility_to | 1.57111091 |
| 18 | MP0010678_abnormal_skin_adnexa | 1.47546366 |
| 19 | MP0002736_abnormal_nociception_after | 1.45076522 |
| 20 | MP0001915_intracranial_hemorrhage | 1.29648057 |
| 21 | MP0000428_abnormal_craniofacial_morphol | 1.16392992 |
| 22 | MP0001764_abnormal_homeostasis | 1.15805752 |
| 23 | MP0001968_abnormal_touch/_nociception | 1.11044938 |
| 24 | MP0001293_anophthalmia | 1.09024205 |
| 25 | MP0001286_abnormal_eye_development | 1.04028397 |
| 26 | MP0003942_abnormal_urinary_system | 1.02590778 |
| 27 | MP0000490_abnormal_crypts_of | 1.00652482 |
| 28 | MP0001545_abnormal_hematopoietic_system | 0.99972946 |
| 29 | MP0005397_hematopoietic_system_phenotyp | 0.99972946 |
| 30 | MP0003453_abnormal_keratinocyte_physiol | 0.99343313 |
| 31 | MP0001963_abnormal_hearing_physiology | 0.99241722 |
| 32 | MP0000026_abnormal_inner_ear | 0.96538553 |
| 33 | MP0005501_abnormal_skin_physiology | 0.95589508 |
| 34 | MP0005360_urolithiasis | 0.93685391 |
| 35 | MP0003763_abnormal_thymus_physiology | 0.92259507 |
| 36 | MP0002735_abnormal_chemical_nociception | 0.81580780 |
| 37 | MP0000470_abnormal_stomach_morphology | 0.80076500 |
| 38 | MP0003646_muscle_fatigue | 0.79472903 |
| 39 | MP0002109_abnormal_limb_morphology | 0.77058374 |
| 40 | MP0002019_abnormal_tumor_incidence | 0.76851770 |
| 41 | MP0004147_increased_porphyrin_level | 0.76838380 |
| 42 | MP0008872_abnormal_physiological_respon | 0.76617775 |
| 43 | MP0000858_altered_metastatic_potential | 0.73937341 |
| 44 | MP0003329_amyloid_beta_deposits | 0.72448031 |
| 45 | MP0000358_abnormal_cell_content/ | 0.72386623 |
| 46 | MP0008058_abnormal_DNA_repair | 0.71505192 |
| 47 | MP0010155_abnormal_intestine_physiology | 0.71204087 |
| 48 | MP0005076_abnormal_cell_differentiation | 0.71178630 |
| 49 | MP0002184_abnormal_innervation | 0.71136433 |
| 50 | MP0003195_calcinosis | 0.69591918 |
| 51 | MP0005253_abnormal_eye_physiology | 0.68839538 |
| 52 | MP0002837_dystrophic_cardiac_calcinosis | 0.67673844 |
| 53 | MP0002210_abnormal_sex_determination | 0.66187955 |
| 54 | MP0002115_abnormal_skeleton_extremities | 0.66105820 |
| 55 | MP0004885_abnormal_endolymph | 0.65043623 |
| 56 | MP0005645_abnormal_hypothalamus_physiol | 0.60921735 |
| 57 | MP0009763_increased_sensitivity_to | 0.60388119 |
| 58 | MP0005332_abnormal_amino_acid | 0.59985803 |
| 59 | MP0000477_abnormal_intestine_morphology | 0.59937696 |
| 60 | MP0004742_abnormal_vestibular_system | 0.56673726 |
| 61 | MP0003638_abnormal_response/metabolism_ | 0.55380179 |
| 62 | MP0001986_abnormal_taste_sensitivity | 0.53336701 |
| 63 | MP0005508_abnormal_skeleton_morphology | 0.51764393 |
| 64 | MP0003252_abnormal_bile_duct | 0.51490988 |
| 65 | MP0008875_abnormal_xenobiotic_pharmacok | 0.51109324 |
| 66 | MP0002938_white_spotting | 0.50859932 |
| 67 | MP0005646_abnormal_pituitary_gland | 0.49947049 |
| 68 | MP0009046_muscle_twitch | 0.48877222 |
| 69 | MP0008995_early_reproductive_senescence | 0.48868368 |
| 70 | MP0000538_abnormal_urinary_bladder | 0.48457252 |
| 71 | MP0000432_abnormal_head_morphology | 0.48180524 |
| 72 | MP0005197_abnormal_uvea_morphology | 0.47486055 |
| 73 | MP0003936_abnormal_reproductive_system | 0.46649741 |
| 74 | MP0002752_abnormal_somatic_nervous | 0.45603735 |
| 75 | MP0005085_abnormal_gallbladder_physiolo | 0.45482258 |
| 76 | MP0002136_abnormal_kidney_physiology | 0.44640924 |
| 77 | MP0002272_abnormal_nervous_system | 0.44341118 |
| 78 | MP0005377_hearing/vestibular/ear_phenot | 0.42665858 |
| 79 | MP0003878_abnormal_ear_physiology | 0.42665858 |
| 80 | MP0000681_abnormal_thyroid_gland | 0.40275633 |
| 81 | MP0009672_abnormal_birth_weight | 0.38471634 |
| 82 | MP0002160_abnormal_reproductive_system | 0.38429266 |
| 83 | MP0002405_respiratory_system_inflammati | 0.37660715 |
| 84 | MP0000372_irregular_coat_pigmentation | 0.37633129 |
| 85 | MP0000604_amyloidosis | 0.36374941 |
| 86 | MP0005551_abnormal_eye_electrophysiolog | 0.35964487 |
| 87 | MP0002113_abnormal_skeleton_development | 0.35375212 |
| 88 | MP0001175_abnormal_lung_morphology | 0.35090921 |
| 89 | MP0000049_abnormal_middle_ear | 0.34687983 |
| 90 | MP0005391_vision/eye_phenotype | 0.33960878 |
| 91 | MP0002557_abnormal_social/conspecific_i | 0.32916366 |
| 92 | MP0005025_abnormal_response_to | 0.31731721 |
| 93 | MP0004019_abnormal_vitamin_homeostasis | 0.30982602 |
| 94 | MP0003890_abnormal_embryonic-extraembry | 0.30824049 |
| 95 | MP0002139_abnormal_hepatobiliary_system | 0.30383401 |
| 96 | MP0002102_abnormal_ear_morphology | 0.29819068 |
| 97 | MP0001970_abnormal_pain_threshold | 0.29553436 |
| 98 | MP0009745_abnormal_behavioral_response | 0.29248349 |
| 99 | MP0009643_abnormal_urine_homeostasis | 0.29047185 |
| 100 | MP0000163_abnormal_cartilage_morphology | 0.28702633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Duplicated collecting system (HP:0000081) | 8.72865977 |
| 2 | Long foot (HP:0001833) | 8.16868362 |
| 3 | Abnormality of the renal collecting system (HP:0004742) | 7.88380139 |
| 4 | Large for gestational age (HP:0001520) | 7.00963782 |
| 5 | Abnormality of fatty-acid metabolism (HP:0004359) | 6.21573518 |
| 6 | Adactyly (HP:0009776) | 6.07880036 |
| 7 | Acute lymphatic leukemia (HP:0006721) | 6.07838375 |
| 8 | Hypoplastic pelvis (HP:0008839) | 5.85748959 |
| 9 | Progressive muscle weakness (HP:0003323) | 5.56591420 |
| 10 | Dry hair (HP:0011359) | 5.48693604 |
| 11 | Autoamputation (HP:0001218) | 5.09649524 |
| 12 | Brushfield spots (HP:0001088) | 4.93278916 |
| 13 | Ureteral duplication (HP:0000073) | 4.89532900 |
| 14 | Ureteral stenosis (HP:0000071) | 4.87958966 |
| 15 | Pulmonary artery stenosis (HP:0004415) | 4.78015269 |
| 16 | Reduced subcutaneous adipose tissue (HP:0003758) | 4.62837740 |
| 17 | Steatorrhea (HP:0002570) | 4.62618091 |
| 18 | Ureteral obstruction (HP:0006000) | 4.50954846 |
| 19 | Hypoplastic nipples (HP:0002557) | 4.39678572 |
| 20 | Menstrual irregularities (HP:0000858) | 4.38640316 |
| 21 | Severe muscular hypotonia (HP:0006829) | 4.17519205 |
| 22 | Abnormal ventriculo-arterial connection (HP:0011563) | 3.76105545 |
| 23 | Transposition of the great arteries (HP:0001669) | 3.76105545 |
| 24 | Abnormal connection of the cardiac segments (HP:0011545) | 3.76105545 |
| 25 | Abnormal auditory evoked potentials (HP:0006958) | 3.68768477 |
| 26 | Broad-based gait (HP:0002136) | 3.62845722 |
| 27 | Sudden death (HP:0001699) | 3.59422123 |
| 28 | Fat malabsorption (HP:0002630) | 3.59051330 |
| 29 | Increased number of teeth (HP:0011069) | 3.52894004 |
| 30 | Anhidrosis (HP:0000970) | 3.36957532 |
| 31 | Polyneuropathy (HP:0001271) | 3.19945443 |
| 32 | Palmoplantar hyperkeratosis (HP:0000972) | 3.15999447 |
| 33 | Polymicrogyria (HP:0002126) | 3.07171061 |
| 34 | Wide intermamillary distance (HP:0006610) | 3.06294198 |
| 35 | Abnormality of vision evoked potentials (HP:0000649) | 3.02216839 |
| 36 | Decreased muscle mass (HP:0003199) | 2.99986866 |
| 37 | Palmar hyperkeratosis (HP:0010765) | 2.98116818 |
| 38 | Decreased lacrimation (HP:0000633) | 2.97655351 |
| 39 | Epiphyseal stippling (HP:0010655) | 2.82643677 |
| 40 | Rhabdomyolysis (HP:0003201) | 2.76182146 |
| 41 | Flat face (HP:0012368) | 2.75545514 |
| 42 | Myoglobinuria (HP:0002913) | 2.72429724 |
| 43 | Clubbing of toes (HP:0100760) | 2.71021791 |
| 44 | Broad nasal tip (HP:0000455) | 2.59143932 |
| 45 | Chorioretinal coloboma (HP:0000567) | 2.58994985 |
| 46 | Plantar hyperkeratosis (HP:0007556) | 2.50327289 |
| 47 | Anxiety (HP:0000739) | 2.45943629 |
| 48 | Female pseudohermaphroditism (HP:0010458) | 2.44979291 |
| 49 | Generalized amyotrophy (HP:0003700) | 2.42959109 |
| 50 | Large hands (HP:0001176) | 2.38338496 |
| 51 | Lactic acidosis (HP:0003128) | 2.25464542 |
| 52 | Posterior embryotoxon (HP:0000627) | 2.24437972 |
| 53 | Hypoplastic iliac wings (HP:0002866) | 2.21754219 |
| 54 | Abnormality of the line of Schwalbe (HP:0008048) | 2.21127655 |
| 55 | Purpura (HP:0000979) | 2.10034734 |
| 56 | Overfolded helix (HP:0000396) | 2.09409795 |
| 57 | Widely spaced teeth (HP:0000687) | 2.08874794 |
| 58 | Basal ganglia calcification (HP:0002135) | 2.02297715 |
| 59 | Spastic tetraplegia (HP:0002510) | 2.00948225 |
| 60 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 11.8205487 |
| 61 | Abnormal epiphyseal ossification (HP:0010656) | 1.99133108 |
| 62 | Steppage gait (HP:0003376) | 1.97045567 |
| 63 | Aplasia/Hypoplasia of the nipples (HP:0006709) | 1.93936817 |
| 64 | Arterial thrombosis (HP:0004420) | 1.91305379 |
| 65 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.87787507 |
| 66 | Gangrene (HP:0100758) | 1.85827139 |
| 67 | External ear malformation (HP:0008572) | 1.82636153 |
| 68 | Prenatal maternal abnormality (HP:0002686) | 1.79873057 |
| 69 | Arthrogryposis multiplex congenita (HP:0002804) | 1.78532725 |
| 70 | Congenital onset (HP:0003577) | 1.76637164 |
| 71 | Thickened calvaria (HP:0002684) | 1.76458829 |
| 72 | Abnormally folded helix (HP:0008544) | 1.75944838 |
| 73 | Primary adrenal insufficiency (HP:0008207) | 1.75593997 |
| 74 | Metabolic acidosis (HP:0001942) | 1.75422645 |
| 75 | Birth length less than 3rd percentile (HP:0003561) | 1.74183613 |
| 76 | Pulmonary embolism (HP:0002204) | 1.74175681 |
| 77 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.74078923 |
| 78 | Abnormality of alanine metabolism (HP:0010916) | 1.74078923 |
| 79 | Hyperalaninemia (HP:0003348) | 1.74078923 |
| 80 | Foot dorsiflexor weakness (HP:0009027) | 1.72682278 |
| 81 | Congenital sensorineural hearing impairment (HP:0008527) | 1.69026270 |
| 82 | Absent toe (HP:0010760) | 1.67523605 |
| 83 | Generalized muscle weakness (HP:0003324) | 1.65570377 |
| 84 | Dysdiadochokinesis (HP:0002075) | 1.63520743 |
| 85 | Pendular nystagmus (HP:0012043) | 1.62718035 |
| 86 | Abnormality of the foot musculature (HP:0001436) | 1.60869739 |
| 87 | Scrotal hypoplasia (HP:0000046) | 1.59442205 |
| 88 | Thickened nuchal skin fold (HP:0000474) | 1.59177023 |
| 89 | Depressed nasal ridge (HP:0000457) | 1.52044889 |
| 90 | Hyperammonemia (HP:0001987) | 1.46377151 |
| 91 | Retinopathy (HP:0000488) | 1.46106608 |
| 92 | Stereotypic behavior (HP:0000733) | 1.46102147 |
| 93 | Short philtrum (HP:0000322) | 1.45257461 |
| 94 | Hammertoe (HP:0001765) | 1.43930741 |
| 95 | Brachycephaly (HP:0000248) | 1.42770832 |
| 96 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.41846187 |
| 97 | Congenital stationary night blindness (HP:0007642) | 1.41675378 |
| 98 | Increased serum lactate (HP:0002151) | 1.41007950 |
| 99 | Postnatal growth retardation (HP:0008897) | 1.36247381 |
| 100 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.35328436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MKNK1 | 6.77597845 |
| 2 | TAOK2 | 5.33270816 |
| 3 | TAOK1 | 5.29851756 |
| 4 | MAP2K3 | 4.07636511 |
| 5 | MAP3K3 | 4.02862449 |
| 6 | MAP3K11 | 3.97674980 |
| 7 | JAK3 | 2.49127192 |
| 8 | MKNK2 | 11.4208798 |
| 9 | ABL2 | 1.93100455 |
| 10 | DYRK1A | 1.71279537 |
| 11 | MAP3K5 | 1.37996751 |
| 12 | SRPK1 | 1.14691318 |
| 13 | MAP3K1 | 0.86519498 |
| 14 | CHEK2 | 0.79272524 |
| 15 | WNK4 | 0.56913275 |
| 16 | MAP3K8 | 0.54966604 |
| 17 | PRKCQ | 0.54244929 |
| 18 | ADRBK2 | 0.43175488 |
| 19 | GRK1 | 0.38609432 |
| 20 | VRK2 | 0.34360375 |
| 21 | WNK3 | 0.32732310 |
| 22 | TIE1 | 0.32684737 |
| 23 | CSNK1A1 | 0.28657765 |
| 24 | TXK | 0.23617919 |
| 25 | INSRR | 0.22378570 |
| 26 | MAP2K6 | 0.21815073 |
| 27 | FRK | 0.21102024 |
| 28 | TLK1 | 0.18049671 |
| 29 | PINK1 | 0.18034073 |
| 30 | GRK7 | 0.16778723 |
| 31 | OBSCN | 0.16402201 |
| 32 | IGF1R | 0.15856581 |
| 33 | PRKCD | 0.15742001 |
| 34 | ACVR1B | 0.15654190 |
| 35 | ABL1 | 0.14596085 |
| 36 | GRK5 | 0.14481310 |
| 37 | VRK1 | 0.13922161 |
| 38 | MAP4K2 | 0.13881198 |
| 39 | ZAK | 0.11502150 |
| 40 | ADRBK1 | 0.10201969 |
| 41 | TSSK6 | 0.10164706 |
| 42 | CSNK2A2 | 0.09936066 |
| 43 | DYRK2 | 0.09460275 |
| 44 | PRKCA | 0.08372656 |
| 45 | PHKG1 | 0.07795842 |
| 46 | PHKG2 | 0.07795842 |
| 47 | AURKA | 0.07750688 |
| 48 | CSNK2A1 | 0.07406515 |
| 49 | MUSK | 0.06851540 |
| 50 | TNIK | 0.06634818 |
| 51 | CSNK1E | 0.06164719 |
| 52 | MAPK13 | 0.06045850 |
| 53 | MAP4K1 | 0.05767485 |
| 54 | PRKCG | 0.04422627 |
| 55 | KDR | 0.04190462 |
| 56 | BMPR1B | 0.04150479 |
| 57 | EIF2AK3 | 0.03197937 |
| 58 | NEK1 | 0.03180749 |
| 59 | PRKACA | 0.03144169 |
| 60 | TGFBR1 | 0.02284838 |
| 61 | CAMK2D | 0.01567159 |
| 62 | PRKCE | 0.01349346 |
| 63 | PRKCB | 0.00598085 |
| 64 | TAOK3 | 0.00394157 |
| 65 | PIM2 | 0.00339211 |
| 66 | CAMK2A | 0.00329460 |
| 67 | FGR | -0.0637126 |
| 68 | SYK | -0.0631103 |
| 69 | CSNK1G3 | -0.0616022 |
| 70 | CCNB1 | -0.0563113 |
| 71 | MARK1 | -0.0554440 |
| 72 | CSNK1G1 | -0.0510072 |
| 73 | DAPK3 | -0.0501388 |
| 74 | MAPK15 | -0.0497410 |
| 75 | EPHA4 | -0.0492066 |
| 76 | STK16 | -0.0477602 |
| 77 | KIT | -0.0473043 |
| 78 | ERBB4 | -0.0472764 |
| 79 | DDR2 | -0.0443843 |
| 80 | TAF1 | -0.0435972 |
| 81 | WNK1 | -0.0427841 |
| 82 | SRC | -0.0417422 |
| 83 | PLK2 | -0.0391688 |
| 84 | MATK | -0.0357598 |
| 85 | BCKDK | -0.0354783 |
| 86 | TGFBR2 | -0.0333927 |
| 87 | CAMK2B | -0.0313081 |
| 88 | PIK3CG | -0.0276103 |
| 89 | PLK3 | -0.0267386 |
| 90 | PLK4 | -0.0255503 |
| 91 | MYLK | -0.0196213 |
| 92 | CAMK2G | -0.0181070 |
| 93 | NTRK2 | -0.0155147 |
| 94 | ITK | -0.0138449 |
| 95 | NUAK1 | -0.0120485 |
| 96 | EIF2AK1 | -0.0074076 |
| 97 | DAPK2 | -0.0051177 |
| 98 | STK39 | -0.0027460 |
| 99 | OXSR1 | -0.0005545 |
| 100 | TEC | -0.0003777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 7.18472630 |
| 2 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 5.75543847 |
| 3 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.46212078 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.15851949 |
| 5 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.15333483 |
| 6 | Taste transduction_Homo sapiens_hsa04742 | 3.13285967 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.90677660 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.80107083 |
| 9 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.55366484 |
| 10 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.45509246 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.39562770 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.08450528 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.96814028 |
| 14 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.87897867 |
| 15 | Lysine degradation_Homo sapiens_hsa00310 | 1.83773673 |
| 16 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.63622675 |
| 17 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.40853983 |
| 18 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.34220174 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.19576998 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.17707981 |
| 21 | Nicotine addiction_Homo sapiens_hsa05033 | 1.07167602 |
| 22 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.02773843 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01155571 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.96367814 |
| 25 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.96035028 |
| 26 | Amoebiasis_Homo sapiens_hsa05146 | 0.94931430 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.91840825 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.90314421 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.89667705 |
| 30 | Asthma_Homo sapiens_hsa05310 | 0.87687935 |
| 31 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.82222368 |
| 32 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.81848421 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80944275 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79512254 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.76514760 |
| 36 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.75283721 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.74199567 |
| 38 | Phototransduction_Homo sapiens_hsa04744 | 0.73791907 |
| 39 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.69632677 |
| 40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.68318561 |
| 41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.67400865 |
| 42 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.66892520 |
| 43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.64908075 |
| 44 | Allograft rejection_Homo sapiens_hsa05330 | 0.62631665 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.61184732 |
| 46 | Huntingtons disease_Homo sapiens_hsa05016 | 0.61178676 |
| 47 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60295837 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.56941895 |
| 49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.56471051 |
| 50 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54976120 |
| 51 | Purine metabolism_Homo sapiens_hsa00230 | 0.54622233 |
| 52 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.54413566 |
| 53 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.52700122 |
| 54 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51339454 |
| 55 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50702063 |
| 56 | Olfactory transduction_Homo sapiens_hsa04740 | 0.50069572 |
| 57 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.48937108 |
| 58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.48765500 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48703869 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46975954 |
| 61 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.46153201 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45919924 |
| 63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.45707535 |
| 64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.44875971 |
| 65 | Parkinsons disease_Homo sapiens_hsa05012 | 0.43860077 |
| 66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43364628 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43201942 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43191120 |
| 69 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.42863208 |
| 70 | RNA transport_Homo sapiens_hsa03013 | 0.41333543 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41150655 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.40009599 |
| 73 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.39050907 |
| 74 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.38079730 |
| 75 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36933119 |
| 76 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.35412336 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.34977871 |
| 78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.33985790 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.32765560 |
| 80 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.31190661 |
| 81 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.29789605 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.28598767 |
| 83 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.27251830 |
| 84 | GABAergic synapse_Homo sapiens_hsa04727 | 0.26853423 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.25980950 |
| 86 | Homologous recombination_Homo sapiens_hsa03440 | 0.25938505 |
| 87 | Morphine addiction_Homo sapiens_hsa05032 | 0.24844042 |
| 88 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.24284187 |
| 89 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.24241391 |
| 90 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.24238552 |
| 91 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.24197787 |
| 92 | Ribosome_Homo sapiens_hsa03010 | 0.23322642 |
| 93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.22053994 |
| 94 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.20337688 |
| 95 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.18001450 |
| 96 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.17743796 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.16987923 |
| 98 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.16857710 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.16689994 |
| 100 | Alzheimers disease_Homo sapiens_hsa05010 | 0.16526493 |

